Marvin Slepian

Regents' Professor, Professor of Medicine and Medical Imaging

Professor of Materials Science & Engineering

Professor and Associate Department Head, Clinical & Industrial Affairs, Biomedical Engineering

Director, Arizona Center for Accelerated Biomedical Innovation

Portrait of Dr. Marvin Slepian


MARV'S TALK: Stretchable Electronics: On or In You for Health

Health care in the US and worldwide is under increasing pressures: financial, population and disease-burden. Paradigms are shifting, with care morphing from a traditional, large population, one-size-fits-all approach to a focus on personalized, precision individual care; and from “sick care” to a hope for “well care” and prevention. Central in this is the need for early, accurate, and personalized diagnostics and therapeutics. To move beyond large lab-based systems to mobile, home and “on person” systems, we need new materials. Learn about novel advances in materials development, specifically the emergence of stretchable, transient and piezo electronic materials, new polymer- and paper-based systems such as smart skins, wearables/implantables, body-powered devices, and edible electronics.

ABOUT MARV:

Marvin “Marv”  J. Slepian, MD, is Professor of Medicine, Professor and Associate Department Head of BioMedical Engineering and McGuire Scholar in the Eller College of Management, at the University of Arizona. He is the Director of the Arizona Center for Accelerated Biomedical Innovation (ACABI) – a “creativity engine,” focused on novel solution development for unmet medical needs. Over his career he has developed and brought to the clinic a number of innovative technologies, using his unique and creative approach to problem solving.  He is the author or coauthor of more than 250 publications in journals such as Science, Nature Materials, and  the New England Journal of Medicine.  He has more than 55 issued and filed patents and has been the founder of numerous medical device companies including FOCAL (NASDAQ), Endotex, Angiotrax, Hansen Medical (NASDAQ), Arsenal, 480 BioMedical, MC10 and SynCardia, bringing many new devices to market, including most notably the Total Artificial Heart. 

Dr. Slepian attended Princeton and received his MD from the University of Cincinnati.  He completed fellowships in Internal Medicine at NYU–Bellevue, clinical residency at Johns Hopkins University, Interventional Cardiology and research fellowship in Artificial Organs at the Cleveland Clinic, and received post-doctoral training in Chemical Engineering and Polymer Chemistry at MIT.  Dr. Slepian has an extensive research career leading to the development of innovative diagnostics and therapeutics for cardiovascular diseases. He has received multiple awards and recognition for his academic and translational research including: the American Heart Association Award for the Most Significant Advance in Cardiovascular Medicine, election as fellow of the American Institute for Medical and Biological Engineering and as fellow of the National Academy of Inventors. He is a serial innovator, inventor and entrepreneur brining several medical devices to market, most notably the Total Artificial Heart.